Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on: May 14,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on:May 14,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on: June 22,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on:June 22,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on: March 30,2024

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on:March 30,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on: August 27,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on:August 27,2024

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

by British Medical JournalCredit: Unsplash/CC0 Public DomainCases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also

Updated on: March 20,2024

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

by British Medical JournalCredit: Unsplash/CC0 Public DomainCases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also

Updated on:March 20,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on: June 24,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on:June 24,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on: February 01,2024

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on:February 01,2024

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Updated on: January 25,2024

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Updated on:January 25,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on: January 28,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on:January 28,2024

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Updated on: December 28,2023

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Updated on:December 28,2023